πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Lxo Ireland Designated Patents

Full USPTO pharma patent portfolio for Lxo Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
201
Expiring ≀24m
3

Quick answer

Lxo Ireland Designated has 201 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months β€” use filters for patent-cliff planning.

Page 3 of 5

  1. US 8957047

    GLA monotherapy for use in cancer treatment

    Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8912175

    Topical compositions for treatment of skin conditions

    Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8901199

    Compositions and methods for UV-curable cosmetic nail coatings

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8888902

    Portable oxygen enrichment device and method of use

    Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8883161

    Fusion polypeptide against EB virus-induced tumor and colicin Ia mutant

    Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8865694

    Topical compositions for treatment of skin conditions

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8802836

    Cloning and recombinant productions of Vespula venom protease and methods of use thereof

    Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8796320

    1,3,4-Oxadiazole-2-carboxamide compound

    Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8778347

    Fluorescent neutralization and adherence inhibition assays

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8735382

    Infusion and injection solution of levodopa

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8710231

    Inhibitor of casein kinase 1delta and casein kinase 1E

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8658648

    Modified chloroquines with single ring moiety or fused ring moiety

    Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8647837

    Artificial tissue constructs comprising alveolar cells and methods for using the same

    Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8563503

    Antibiotic, its nucleotide sequence, methods of construction and uses thereof

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8541482

    Removable multilayer nail coating system and methods therefore

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8492454

    Removable color layer for artificial nail coatings and methods therefore

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8481010

    Covalently bonding nail primer

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8466290

    STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient

    Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8399537

    Compositions and methods for nail coatings

    Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8367742

    Removable color layer for artificial nail coatings and methods therefore

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8323662

    Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8263677

    Removable color gel basecoat for artificial nail coatings and methods therefore

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8263657

    Inhibitors against the production and release of inflammatory cytokines

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8212010

    Sphingosine 1-phosphate antagonism

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8203005

    Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8187872

    Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8124058

    Artificial nail compositions and related methods

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8119769

    Complement depletion using recombinant human C-3 derivatives

    Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8097759

    Inflammatory cytokine release inhibitor

    Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8097610

    Derivative having PPAR agonistic activity

    Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8080416

    Method for determining the immunogenicity of an antigen

    Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8044236

    Carboxilic acid derivatives

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8030070

    Artificial lymphoid tissue equivalent

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7998992

    Oxazolidinone derivative having inhibitory activity on 11Ξ²-hydroxysteroid dehydrogenase type 1

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7918899

    Variably crosslinked tissue

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7888068

    Cloning of honey bee allergen C

    Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7884234

    N-phenyloxamide derivatives

    Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7846690

    Cloning of honey bee allergen

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7785806

    Method for determining the immunogenicity of an antigen

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7709257

    Models for vaccine assessment

    Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7700655

    Antiallergic agents

    Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7674953

    Method for producing transgenic plants with increased yield, comprising expressing of haemoglobin from Arabidopsis

    Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7671058

    N-(3,4-disubstituted phenyl) salicylamide derivatives

    Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7626042

    O-substituted hydroxyaryl derivatives

    Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7598418

    Amide derivatives

    Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7566552

    Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors

    Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7553931

    Complement depletion using recombinant human C3-derivatives

    Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7547716

    Sulfonamide derivatives

    Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Lxo Ireland Designated have?

201 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Lxo Ireland Designated patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.